As of April 2024 Prothena has a market cap of $1.10 Billion. This makes Prothena the world's 4992th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $1.10 B | -43.37% |
2023 | $1.95 B | -37.3% |
2022 | $3.11 B | 35.14% |
2021 | $2.30 B | 380.07% |
2020 | $0.47 B | -24.09% |
2019 | $0.63 B | 53.82% |
2018 | $0.41 B | -71.51% |
2017 | $1.44 B | -15.04% |
2016 | $1.69 B | -21.53% |
2015 | $2.16 B | 280.26% |
2014 | $0.56 B | -1.91% |
2013 | $0.57 B | 347.29% |
2012 | $0.12 B |
On Apr 25th, 2024 the market cap of Prothena was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Amarin Corporation
AMRN | $0.35 B | -68.07% | ๐ฎ๐ช Ireland |
Alnylam Pharmaceuticals
ALNY | $18.17 B | 1,545.32% | ๐บ๐ธ USA |
Alkermes ALKS | $4.17 B | 277.58% | ๐ฎ๐ช Ireland |